Glen Eagle Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-30	Closed	-$903	–	680
2017 Q4	$903	Hold	30	–	–	﹤0.01%	610
2017 Q3	$1.13K	Hold	30	–	–	﹤0.01%	609
2017 Q2	$837	Buy	+30	New	+$837	﹤0.01%	569